Wazoku Earns Landmark B Corp™ Certification 6 Oct Written by Alexandra Collingbourne Alexandra Collingbourne Previous Previous Solvemed raises £3.2m for ocular identification of neurological diseases Next Next Drug discovery firm strengthens team
Wazoku Earns Landmark B Corp™ Certification 6 Oct Written by Alexandra Collingbourne Alexandra Collingbourne